Alnylam Pharmaceuticals Inc (ALNY) — Free Cash Flow Generation Index
Alnylam Pharmaceuticals Inc (ALNY) has a Free Cash Flow Generation Index of 0.86x as of December 2025. Free cash flow of $140.26 Million represents 1% of operating cash flow ($163.56 Million). See ALNY working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Alnylam Pharmaceuticals Inc Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Alnylam Pharmaceuticals Inc across 4 annual periods. Explore Alnylam Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Alnylam Pharmaceuticals Inc (2007–2025)
Year-by-year Free Cash Flow Generation Index for Alnylam Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of Alnylam Pharmaceuticals Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | $465.38 Million | $524.08 Million | $58.70 Million | ▲ +120.5% |
| 2023 | 0.40x | $41.95 Million | $104.16 Million | $62.21 Million | ▼ -51.8% |
| 2008 | 0.84x | $54.73 Million | $65.49 Million | $10.76 Million | ▼ -13.0% |
| 2007 | 0.96x | $188.73 Million | $196.52 Million | $7.79 Million | — |